MR vs. FFR in Non-Culprit Lesions

Magnetic resonance (MR) and fractional flow reserve (FFR) correlate moderately as regards the assessment of non-culprit lesions in patients admitted with acute myocardial infarction who underwent primary angioplasty. For a similar degree of diagnostic accuracy, we would require a visual, semiquantitative, or fully quantitative comprehensive assessment of lesions.

Resonancia vs FFR en lesiones no culpables del infarto

This work, soon to be published in J Am Coll Cardiol Img, looked into the degree of correlation between FFR and MR in the assessment of non-culprit lesions after an infarction.

The study included 77 patients who underwent primary angioplasty and had at least one non-culprit lesion with intermediate stenosis (between 70% and 90%). All patients were assessed through FFR and MR one month after infarction. The MR protocol included stress and rest perfusion, cine imaging, and late gadolinium enhancement. Fully quantitative, semiquantitative, and visual analysis of myocardial perfusion were compared against a reference FFR.


Read also: Predilation in TAVR: Definitive Data for Easier Decision-Making?


Visual analysis through MR displayed an area under the curve of 0.74, with a sensitivity of 73% and a specificity of 70%. The semiquantitative analysis had results similar to those derived from the visual analysis. The MR myocardial blood flow was slightly better than the other parameters, but it still was far from perfect (an area under the curve of 0.82, with a sensitivity of 82% and a specificity of 71%).

Conclusion

Cardiac magnetic resonance and invasive fractional flow reserve have a moderately good correlation as regards non-culprit lesions in patients who suffered from an acute myocardial infarction. All MR parameters yielded a similar diagnostic performance and do not seem enough to replace FFR.

Original Title: Cardiac Magnetic Resonance for Evaluating Nonculprit Lesions After Myocardial Infarction Comparison With Fractional Flow Reserve.

Reference: Henk Everaars et al. J Am Coll Cardiol Img 2020, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....